Wednesday 22 May 2019

Children with cancer wait an average of 6.5 years longer than adults to access new drugs

Cancer drugs approved by the U.S. Food and Drug Administration (FDA) took a median of 6.5 years to go from the first clinical trial in adults to the first trial in children, according to a study at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center. The study was published in the May issue of the European Journal of Cancer.

* This article was originally published here

Experts urge stronger emphasis on cancer prevention in older population

Cancer prevention efforts rarely focus on the distinct needs and circumstances of older people, who are at greatest risk for developing cancer, but society can do more to reduce cancer risk and preserve health as adults enter their 60s, 70s, and beyond—according to a new supplement to the journal The Gerontologist from The Gerontological Society of America.

* This article was originally published here

Samsung at foundry event talks about 3nm, MBCFET developments

"The nanometer process deals with the space between the transistors mounted on a substrate at a nanometer level," said Pulse.

* This article was originally published here

Flamingoes, elephants and sharks: How do blind adults learn about animal appearance?

They've never seen animals like hippos and sharks but adults born blind have rich insight into what they look like, a new Johns Hopkins University study found.

* This article was originally published here

Young athletes who require ACL reconstruction may benefit from additional procedure

An anterior cruciate ligament (ACL) tear, an injury of the knee, can be devastating to a young athlete. While the ACL can be reconstructed through surgery, there is a high risk of re-injury in patients under the age of 25. In the largest clinical trial of its kind, researchers at Lawson Health Research Institute have shown that performing an additional surgical procedure called lateral extra-articular tenodesis (LET) may reduce the risk of ACL re-injury in young athletes.

* This article was originally published here

Firearm mortality highest in young men, and is associated with race and education

Firearms are a leading contributor to mortality in men aged 15-34 years in the USA, Mexico, Brazil, and Colombia, according to an observational study using national data for 106.3 million deaths, including 2.5 million firearm deaths in these 4 countries, published in The Lancet Public Health journal.

* This article was originally published here